ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

The Quad should have its own biomanufacturing hub in India

China likely to dominate sector unless allies pool their capabilities

| India
Bharat Biotech's COVID-19 vaccine Covaxin: The world's pandemic response depended on the rapid production of new vaccines through biomanufacturing.   © Reuters

Saurabh Todi is a research analyst in the high-tech geopolitics program of the Takshashila Institution, a policy think tank based in Bengaluru. Shambhavi Naik is Takshashila's head of research.

Biomanufacturing, which uses microorganisms and cell cultures to produce molecules and materials on a large scale, is rapidly rising in importance for Indo-Pacific nations.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more